| CYHS2101901 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-10-21 | | QILU Pharmaceutical Co Ltd | | | view |
| JYHS2300113 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2023-09-06 | | Msn Laboratories Private Ltd | | | view |
| JYHZ2300178 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | License Renew | 2023-04-11 | | | | | view |
| CYHS2101980 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-11-08 | | QILU Pharmaceutical Co Ltd | | | view |
| JYHS2300114 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2023-09-06 | | Msn Laboratories Private Ltd | | | view |
| JYHZ2300177 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | License Renew | 2023-04-11 | | | | | view |
| JYHZ2200023 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | License Renew | 2022-01-21 | | | | | view |
| JYHS2300083 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2023-07-06 | | | | | view |
| CYHS2101732 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-09-15 | | Suzhou Thery Pharmaceutical INC | | | view |
| JYHS2300084 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2023-07-06 | | | | | view |
| CYHS2101733 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-09-15 | | Suzhou Thery Pharmaceutical INC | | | view |
| CYHS2402670 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2024-08-16 | | Shanghai Acebright Pharmaceuticals Co Ltd | | | view |
| JYHB1800422 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2018-04-16 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-06-04 | view |
| JYHB1300824 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2013-06-27 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2014-04-16 | view |
| JYHB2000838 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-06-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-19 | view |
| JYHZ1700033 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | License Renew | 2017-08-03 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2017-10-19 | view |
| JYHB1201067 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2012-10-26 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2013-04-18 | view |
| JYHB1801411 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2018-12-14 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2019-11-18 | view |
| JYHB2001444 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-08-21 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-03 | view |
| JXHL1000096 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Import Drug Application | 2010-04-13 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2010-12-08 | view |
